Paroxetine discontinuation syndrome in association with sertindole therapy.
Walker-Kinnear
M
M
McNaughton
S
S
D000328:Adult; D014150:Antipsychotic Agents / Q000009:adverse effects*; D004347:Drug Interactions; D006801:Humans; D007093:Imidazoles / Q000009:adverse effects*; D007211:Indoles / Q000009:adverse effects*; D008297:Male; D017374:Paroxetine / Q000009:adverse effects*; D017367:Selective Serotonin Reuptake Inhibitors / Q000009:adverse effects*; D013375:Substance Withdrawal Syndrome / Q000209:etiology*
D014150:Antipsychotic Agents; D007093:Imidazoles; D007211:Indoles; D017374:Paroxetine; D017367:Selective Serotonin Reuptake Inhibitors; C066304:sertindole